SEC Form 4 · accession 0001638599-16-000968
ALBANY MOLECULAR RESEARCH INC · AMRI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kevin Oconnor
Director
Period of report
May 31, 2016
Accepted (ET)
Jun 1, 2016 · 4:18 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001065087
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 31, 2016 | M | 5,000 | $10.37 | A | 52,955 | D | |
| Common Stock | May 31, 2016 | S | 5,000 | $14.41 | D | 47,955 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common StockF1 | $10.37 | May 31, 2016 | M | 5,000 | A | — | Jun 1, 2016 | Common Stock | 5,000 | 0 | D |
Explanation of responses
- F1Option grant was fully exercisable on June 1, 2007